- Home
- VHC vs CALC Comparison
VHC vs CALC Comparison
Compare VHC & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VHC
- CALC
- Stock Information
- Founded
- VHC 2005
- CALC 2011
- Country
- VHC United States
- CALC United States
- Employees
- VHC N/A
- CALC N/A
- Industry
- VHC Multi-Sector Companies
- CALC Biotechnology: Pharmaceutical Preparations
- Sector
- VHC Miscellaneous
- CALC Health Care
- Exchange
- VHC Nasdaq
- CALC Nasdaq
- Market Cap
- VHC 54.3M
- CALC 48.1M
- IPO Year
- VHC 1999
- CALC N/A
- Fundamental
- Price
- VHC $13.30
- CALC $2.80
- Analyst Decision
- VHC
- CALC Strong Buy
- Analyst Count
- VHC 0
- CALC 2
- Target Price
- VHC N/A
- CALC $14.50
- AVG Volume (30 Days)
- VHC 13.2K
- CALC 65.9K
- Earning Date
- VHC 08-12-2025
- CALC 08-12-2025
- Dividend Yield
- VHC N/A
- CALC N/A
- EPS Growth
- VHC N/A
- CALC N/A
- EPS
- VHC N/A
- CALC N/A
- Revenue
- VHC $50,000.00
- CALC N/A
- Revenue This Year
- VHC N/A
- CALC N/A
- Revenue Next Year
- VHC N/A
- CALC N/A
- P/E Ratio
- VHC N/A
- CALC N/A
- Revenue Growth
- VHC 733.33
- CALC N/A
- 52 Week Low
- VHC $3.68
- CALC $1.42
- 52 Week High
- VHC $21.53
- CALC $5.97
- Technical
- Relative Strength Index (RSI)
- VHC 41.60
- CALC 54.67
- Support Level
- VHC $14.79
- CALC $2.31
- Resistance Level
- VHC $14.21
- CALC $3.05
- Average True Range (ATR)
- VHC 1.53
- CALC 0.32
- MACD
- VHC -0.51
- CALC -0.07
- Stochastic Oscillator
- VHC 21.67
- CALC 46.93
About VHC VirnetX Holding Corp
VirnetX Holding Corp is engaged in the business of commercializing a portfolio of patents. It is an Internet security software and technology company with patented technology for secure communications. The company's software and technology solutions, including its Secure Domain Name Registry and Technology, VirnetX One, War Room, VirnetX Matrix, and GABRIEL Connection Technology, are designed to be device and location-independent, and enable a secure real-time communication environment for all types of enterprise applications, services and critical infrastructures.
About CALC CalciMedica Inc.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.